UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060842
Receipt number R000066977
Scientific Title Exploratory study evaluating the suppressive effect of the test food on daytime sleepiness
Date of disclosure of the study information 2026/03/06
Last modified on 2026/03/06 09:36:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study evaluating the suppressive effect of the test food on daytime sleepiness

Acronym

Exploratory study evaluating the suppressive effect of the test food on daytime sleepiness

Scientific Title

Exploratory study evaluating the suppressive effect of the test food on daytime sleepiness

Scientific Title:Acronym

Exploratory study evaluating the suppressive effect of the test food on daytime sleepiness

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of a single intake of the test food on daytime sleepiness in comparison with the control food.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Maintenance of Wakefulness Test (MWT)

Key secondary outcomes

Karolinska Sleepiness Scale (KSS)
Microsleep Latency
Oguri-Shirakawa-Azumi Sleep Inventory, Middle-Aged and Aged version (OSA-MA)


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Single intake of the test food on the day of the study

Interventions/Control_2

Single intake of the placebo food on the day of the study

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

59 years-old >=

Gender

Male

Key inclusion criteria

1. Adult male full-time employees of the Research Headquarters whose workplace is the Meiji Innovation Center at the time of obtaining consent.
2. Subjects who have received sufficient explanation about the purpose and content of this study, possess the capacity to consent, and have voluntarily agreed to participate after fully understanding the information provided.

Key exclusion criteria

1. Subjects currently receiving treatment (including medication) for any disease.
2. Subjects with a Body Mass Index (BMI) greater than 25.
3. Subjects whose usual sleep duration, calculated from self reported bedtime and wake up time, is less than 6 hours.
4. Subjects with suspected sleep disorders.
5. Subjects unable to comply with study procedures.
6. Subjects engaged in shift work, night work, or whose primary occupation involves physical labor.
7. Subjects who consume excessive amounts of alcohol (defined as consuming more than 1 go of sake [equivalent to one 500 mL bottle of beer, one double shot of whiskey, or 0.6 go of shochu] three or more times per week).
8. Subjects who smoke.
9. Subjects with known food allergies.
10. Subjects with lactose intolerance.
11. Subjects who self identify as caffeine dependent.
12. Subjects currently participating in or planning to participate in another clinical trial at the start of this study.
13. Subjects deemed inappropriate for participation by the principal investigator.

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Kentarou
Middle name
Last name Nakamura

Organization

Meiji Co., Ltd.

Division name

Nutrition and Food Function Group

Zip code

192-0919

Address

Meiji Innovation Center, 1-29-1 Nanakuni, Hachioji, Tokyo

TEL

042-632-5847

Email

kentarou.nakamura@meiji.com


Public contact

Name of contact person

1st name Kentarou
Middle name
Last name Nakamura

Organization

Meiji Co., Ltd.

Division name

Nutrition and Food Function Group

Zip code

192-0919

Address

Meiji Innovation Center, 1-29-1 Nanakuni, Hachioji, Tokyo

TEL

042-632-5847

Homepage URL


Email

kentarou.nakamura@meiji.com


Sponsor or person

Institute

Meiji Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Meiji Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

1. University of Tsukuba, International Institute for Integrative Sleep Medicine (WPI-IIIS)
2. S'UIMIN Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Meiji Institutional Review Board

Address

1-29-1 Nanakuni, Hachioji, Tokyo, 192-0919, Japan

Tel

042-632-5900

Email

MEIJI.IRB@meiji.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

7

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2025 Year 07 Month 16 Day

Date of IRB

2025 Year 07 Month 17 Day

Anticipated trial start date

2025 Year 08 Month 19 Day

Last follow-up date

2025 Year 11 Month 11 Day

Date of closure to data entry


Date trial data considered complete

2025 Year 12 Month 10 Day

Date analysis concluded

2026 Year 01 Month 16 Day


Other

Other related information



Management information

Registered date

2026 Year 03 Month 06 Day

Last modified on

2026 Year 03 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000066977